Search details
1.
Targeted dual degradation of HER2 and EGFR obliterates oncogenic signaling, overcomes therapy resistance, and inhibits metastatic lesions in HER2-positive breast cancer models.
Drug Resist Updat
; 74: 101078, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38503142
2.
Three-dimensional analysis of the effect of human movement on indoor airflow patterns.
Indoor Air
; 31(2): 587-601, 2021 03.
Article
in English
| MEDLINE | ID: mdl-32870542
3.
Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke: The EXTEND-IA TNK Part 2 Randomized Clinical Trial.
JAMA
; 323(13): 1257-1265, 2020 04 07.
Article
in English
| MEDLINE | ID: mdl-32078683
4.
Non-Coding Micro RNAs and Hypoxia-Inducible Factors Are Selenium Targets for Development of a Mechanism-Based Combination Strategy in Clear-Cell Renal Cell Carcinoma-Bench-to-Bedside Therapy.
Int J Mol Sci
; 19(11)2018 Oct 29.
Article
in English
| MEDLINE | ID: mdl-30380599
5.
NeuroDiag: Software for Automated Diagnosis of Parkinson's Disease Using Handwriting.
IEEE J Transl Eng Health Med
; 12: 291-297, 2024.
Article
in English
| MEDLINE | ID: mdl-38410180
6.
Enhanced inhibition of urinary bladder cancer growth and muscle invasion by allyl isothiocyanate and celecoxib in combination.
Carcinogenesis
; 34(11): 2593-9, 2013 Nov.
Article
in English
| MEDLINE | ID: mdl-23946495
7.
Organ-specific exposure and response to sulforaphane, a key chemopreventive ingredient in broccoli: implications for cancer prevention.
Br J Nutr
; 109(1): 25-32, 2013 Jan 14.
Article
in English
| MEDLINE | ID: mdl-22464629
8.
The principal urinary metabolite of allyl isothiocyanate, N-acetyl-S-(N-allylthiocarbamoyl)cysteine, inhibits the growth and muscle invasion of bladder cancer.
Carcinogenesis
; 33(2): 394-8, 2012 Feb.
Article
in English
| MEDLINE | ID: mdl-22131350
9.
Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer.
J Exp Clin Cancer Res
; 41(1): 184, 2022 Jun 02.
Article
in English
| MEDLINE | ID: mdl-35650607
10.
Loss of peptidase D binding restores the tumor suppressor functions of oncogenic p53 mutants.
Commun Biol
; 4(1): 1373, 2021 12 08.
Article
in English
| MEDLINE | ID: mdl-34880421
11.
Allyl isothiocyanate-rich mustard seed powder inhibits bladder cancer growth and muscle invasion.
Carcinogenesis
; 31(12): 2105-10, 2010 Dec.
Article
in English
| MEDLINE | ID: mdl-20889681
12.
Inhibition of bladder cancer development by allyl isothiocyanate.
Carcinogenesis
; 31(2): 281-6, 2010 Feb.
Article
in English
| MEDLINE | ID: mdl-19955395
13.
Downregulation of cystine transporter xc by irinotecan in human head and neck cancer FaDu xenografts.
Chemotherapy
; 56(3): 223-33, 2010.
Article
in English
| MEDLINE | ID: mdl-20551639
14.
Tumor vascular maturation and improved drug delivery induced by methylselenocysteine leads to therapeutic synergy with anticancer drugs.
Clin Cancer Res
; 14(12): 3926-32, 2008 Jun 15.
Article
in English
| MEDLINE | ID: mdl-18559614
15.
A recombinant human protein targeting HER2 overcomes drug resistance in HER2-positive breast cancer.
Sci Transl Med
; 11(476)2019 01 23.
Article
in English
| MEDLINE | ID: mdl-30674653
16.
Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development.
Oncotarget
; 9(12): 10765-10783, 2018 Feb 13.
Article
in English
| MEDLINE | ID: mdl-29535842
17.
Anticoagulants inhibit proteolytic clearance of plasma amyloid beta.
Oncotarget
; 9(5): 5614-5626, 2018 Jan 19.
Article
in English
| MEDLINE | ID: mdl-29464022
18.
Strong impact of sulfotransferases on DNA adduct formation by 4-aminobiphenyl in bladder and liver in mice.
Cancer Med
; 7(11): 5604-5610, 2018 11.
Article
in English
| MEDLINE | ID: mdl-30306738
19.
PEPD is a pivotal regulator of p53 tumor suppressor.
Nat Commun
; 8(1): 2052, 2017 12 12.
Article
in English
| MEDLINE | ID: mdl-29233996
20.
Dual inhibition of ErbB1 and ErbB2 in cancer by recombinant human prolidase mutant hPEPD-G278D.
Oncotarget
; 7(27): 42340-42352, 2016 Jul 05.
Article
in English
| MEDLINE | ID: mdl-27286447